Published trade mark details for 2508791

This information was published on 2025-05-21T00:06:12 for IP Right Acceptance Published.

Field	Value
(210)	2508791
(220)	20 Dec 2024
(511) (510)	Class 5 Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing Class 42 Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders
(540)
(550)	Figurative
(730)	CG Oncology, Inc.
(750)	Ashurst Australia

 

Find out more about publications on the About page.